 SEATTLE, Oct. 11, 2021 GLOBE NEWSWIRE -- Nautilus Biotechnology, Inc. NASDAQ: NAUT; or Nautilus, a company pioneering a single-molecule protein analysis platform for quantifying the proteome, today announced it will report financial results for the third quarter of fiscal year 2021 before market open on Tuesday, November 2nd, 2021. 